Clinical Trial Update: A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of a Montelukast and Loratadine combination in Mexican participants with allergic rhinitis; the study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Loratadine (Claritin) (loratadine)
• Montelukast (Singulair) (montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2014-11-14